Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
02/12/2002 | US6346656 Increasing resistance of plants or algal cells by genetically engineering a unicellular green alga resistant to porphyrin herbicides |
02/12/2002 | US6346608 MecB |
02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
02/12/2002 | US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer |
02/12/2002 | US6346510 Antiproliferative, anticarcinogenic and antitumor agents |
02/12/2002 | US6346410 Motor proteins and methods for their use |
02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
02/12/2002 | US6346407 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter |
02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
02/12/2002 | US6346405 Amino acid sequence of enzyme involved in aromatic amino acid biosynthesis; fungicides |
02/12/2002 | US6346404 Genes for the biosynthesis of epothilones |
02/12/2002 | US6346394 Dna having specific nucleotide sequence; for recombinant production of enzyme and high yield, industrial scale production of trehalose |
02/12/2002 | US6346393 Polynucleotides encoding a ribonuclease s |
02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
02/12/2002 | US6346379 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes |
02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
02/12/2002 | US6346244 Fungal protein disulfide isomerase |
02/12/2002 | CA2215187C Addition of lactose or other sugars in correcting false susceptibility results for resistant microorganisms in antimicrobial susceptibility tests |
02/12/2002 | CA2214871C Process for preparing spirolaxine and spirolaxine methyl ether |
02/12/2002 | CA2068204C Latency associated peptides and uses therefor |
02/12/2002 | CA1341339C Arg-serpin human plasminogen activator inhibitor designated pai-2 |
02/09/2002 | CA2354726A1 Sodium ion-driven chloride/bi-carbonate exchanger |
02/08/2002 | CA2353772A1 Process for producing a target fermentation product |
02/07/2002 | WO2002010766A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors |
02/07/2002 | WO2002010435A1 Methods of screening novel agents for use in cancer therapy and prevention |
02/07/2002 | WO2002010426A1 Koji molds and use thereof for preparing cholesterol-lowering products |
02/07/2002 | WO2002010425A2 Ascorbic acid production from yeasts |
02/07/2002 | WO2002010420A2 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof |
02/07/2002 | WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S) |
02/07/2002 | WO2002010411A2 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use |
02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
02/07/2002 | WO2002010405A2 A human disintegrin protein |
02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
02/07/2002 | WO2002010399A1 Novel carbonyl reductase, gene thereof and method of using the same |
02/07/2002 | WO2002010394A2 Nucleic acids, by means of which plants with altered metabolite content can be produced |
02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
02/07/2002 | WO2002010387A2 G-protein coupled receptors |
02/07/2002 | WO2002010384A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
02/07/2002 | WO2002010383A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
02/07/2002 | WO2002010382A2 Trp8, trp9 and trp10, markers for cancer |
02/07/2002 | WO2002010381A1 Novel protein inhibitor of apoptosis proteins |
02/07/2002 | WO2002010376A1 HUMAN II TYPE 5α-REDUCTASE PROMOTER GENE AND USE THEREOF |
02/07/2002 | WO2002010369A1 Tumor antigen |
02/07/2002 | WO2002010363A2 Protein phosphatases |
02/07/2002 | WO2002010360A1 Novel dna synthase |
02/07/2002 | WO2002010355A2 Alpha-amylase mutants with altered stability |
02/07/2002 | WO2002010343A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae |
02/07/2002 | WO2002010342A2 Yeast strains |
02/07/2002 | WO2002010341A1 Microsporidia isolate |
02/07/2002 | WO2002010340A1 $i(neospora caninum) isolate |
02/07/2002 | WO2002010333A1 Method for cellular lysis of prokaryotes and eukaryotes or simultaneous cellular lysis or prokaryotes and eukaryotes |
02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
02/07/2002 | WO2002010209A1 Nucleotide sequences which code for the meth gene |
02/07/2002 | WO2002010208A1 Nucleotide sequences which code for the mete gene |
02/07/2002 | WO2002010206A2 Nucleotide sequences which code for the metf gene |
02/07/2002 | WO2002010204A2 G protein-coupled receptors |
02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
02/07/2002 | WO2002010196A2 Identification of a novel glutamine transporter |
02/07/2002 | WO2002009872A2 Biodehalogenating cultures and production thereof |
02/07/2002 | WO2002009647A2 Biological component comprising artificial membrane |
02/07/2002 | WO2002002778A8 Nucleotide sequences which code for the mdha gene from corynebacterium glutamicum |
02/07/2002 | WO2001079507A3 EXPRESSION-REGULATING SEQUENCES AND EXPRESSION PRODUCTS IN THE FIELD OF FILAMENTOUS FUNGI $i(CHRYSOSPORIUM) |
02/07/2002 | WO2001075066A3 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
02/07/2002 | WO2001064878A3 Human transporter proteins and polynucleotides encoding the same |
02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
02/07/2002 | WO2001057193A3 Protein c derivatives |
02/07/2002 | WO2001055329A3 Nucleic acids, proteins, and antibodies |
02/07/2002 | WO2001055315A3 Nucleic acids, proteins, and antibodies |
02/07/2002 | WO2001055297A3 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
02/07/2002 | WO2001055211A3 Fil-1 theta dnas and polypeptides |
02/07/2002 | WO2001053469A3 Phosphatases |
02/07/2002 | WO2001053347A3 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
02/07/2002 | WO2001032831A3 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
02/07/2002 | WO2001031047A3 Microbiological methods for the producing of aromatic aldehydes and/or carboxylic acids |
02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
02/07/2002 | WO2001029224A3 Granulocyte peptide homolog zgpa1 |
02/07/2002 | WO2001018216A3 26176, a novel calpain protease and uses thereof |
02/07/2002 | WO2001018050A9 T2r taste receptor family |
02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
02/07/2002 | WO2000068376A8 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
02/07/2002 | US20020016450 Pressure-enhanced extraction and purification |
02/07/2002 | US20020016446 Recombinant vector and use thereof for exocellular preparation of single molecula antibodies from bacillus subtilis |
02/07/2002 | US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
02/07/2002 | US20020016305 Yeast genes that affect viral replication |
02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
02/07/2002 | US20020015990 Nutrient broth for use in the propagation of preferential microorgansim and generation of foods |
02/07/2002 | US20020015988 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
02/07/2002 | US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
02/07/2002 | US20020015983 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof |
02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
02/07/2002 | US20020015950 Atherosclerosis-associated genes |
02/07/2002 | US20020015757 Xanthan gum broth |
02/07/2002 | US20020015038 System and method for evaluating pockets in protein |
02/07/2002 | DE10048383A1 Protonen-translozierendes Retinalprotein Proton-translocating retinal protein |
02/07/2002 | DE10037111A1 Herstellung eines rekombinanten Proteins in einer prokaryontischen Wirtszelle Producing a recombinant protein in a prokaryotic host cell |
02/07/2002 | DE10037101A1 Rekombinant hergestellte Enzyme mit verbesserter NAD(H)-Akzeptanz Recombinantly produced enzymes with improved NAD (H) -Akzeptanz |